chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Initial and follow-up information has been received from a 78 year old female with irritable bowel syndrome, hypertension, peripheral neuropathy, IVP dye allergy and severe stomach nausea, pain and vomiting with many different prescription pain medicines and antibiotics and a history of two lumbar spinal fusion surgeries who on 24-APR-2007 was vaccinated with a single dose of ZOSTAVAX. Concomitant therapy included ACTONEL, FLONASE, ALTACE, TOPROL XL TABLETS, meprobamate, CLIMARA AND amitriptyline HCL/ clordiazepoxide. On 27-APR-2007 the patient experienced stomach aches and nausea, itching and small rashes on her back, and headaches. She also said that at times she has felt achy all over but she has not had a fever. At the time of the initial report medical attention was not sought. In follow-up it was noted that a pathologist thought the patient's reactions were related to Zostavax. There were no lab tests performed. At the time of the report the patient was recovering, though it was noted that the rash on her back only lasted a few days after treatment with hydrocortisone cream. There was no product quality complaint involved. No further information was provided. Additional information has been requested.  Follow up received 03/27/2009.  Additional information is not expected.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Information has been received from a physician concerning a 60 year old female who was vaccinated with a dose of Zostavax. The patient experienced very mild local rash around the injection site. No further information is available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a health care provider concerning a female who was vaccinated with a dose of Zostavax. Subsequently tow or three days after vaccination, the patient developed shingles on her face. Unspecified medical attention was sought and the patient was treated (unspecified) at the clinic. There was no product quality complaint involved. Additional information has been requested.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Local reaction
Clinical narrative: Information has been received from a physician concerning a 60 year old male with no known medical history or allergies who in October 2006, was vaccinated with a dose of Zostervax. There was no concomitant medication. Subsequently in late April 2007, the patient developed a local reaction. Unspecified medical attention was sought. No laboratory test were performed. There was no product quality complaint involved.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a registered nurse concerning a 72 year old female with sulfa and baetadine allergies who on 26-APR-2007 was vaccinated in the right arm with a first dose of ZOSTAVAX (Merck) (656395/0290U). There was no concomitant medication. On 01-MAY-2007 (previously reported as 28-APR-2007) the patient experienced redness and was swollen on the site of injection. Three days later, on 03-MAY-2007, the patient's redness and swelling at the site of vaccine resolved. Additional information is not expected.
Age: 55.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Migraine, Secondary transmission
Clinical narrative: Information has been received from a female registered nurse in her mid 50"s who administered Zostavax, and broke out in a mild case of shingles. It was reported that she experienced a migraine headache and developed "shingles rash on the forehead". It was noted that the nurse was never vaccinated with Zostavax. Unspecified medical attention was sought. A product quality complaint was not involved. The nurse patient was not vaccinated with a dose of Zostavax. Additional information has been requested. This is one of several reports received from the same source.
Age: 55.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Accidental exposure, Herpes zoster
Clinical narrative: Information has been received from a female registered nurse in her mid 50"s who administered Zostavax, and broke out in a mild case of shingles. It was reported that she experienced a migraine headache and developed "shingles rash on the forehead". It was noted that the nurse was never vaccinated with Zostavax. Unspecified medical attention was sought. A product quality complaint was not involved. The nurse patient was not vaccinated with a dose of Zostavax. Additional information has been requested. This is one of several reports received from the same source.
Age: 55.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Migraine, Secondary transmission
Clinical narrative: Information has been received from a female registered nurse in her mid 50's concerning a female  nurse in her mid 50's who administered Zostavax (Oka/Merck), and broke out in a mild case of shingles. It was reported that she developed "shingles rash on the forehead". It was noted that the nurse was never vaccinated with Zostavax (Oka/Merck). Unspecified medical attention was sought. A product quality complaint was not involved. The nurse patient was not vaccinated with a dose of Zostavax (Oka/Merck). Additional information has been requested. This is one of several reports received from the same source.
Age: 55.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Accidental exposure, Herpes zoster
Clinical narrative: Information has been received from a female registered nurse in her mid 50's concerning a female  nurse in her mid 50's who administered Zostavax (Oka/Merck), and broke out in a mild case of shingles. It was reported that she developed "shingles rash on the forehead". It was noted that the nurse was never vaccinated with Zostavax (Oka/Merck). Unspecified medical attention was sought. A product quality complaint was not involved. The nurse patient was not vaccinated with a dose of Zostavax (Oka/Merck). Additional information has been requested. This is one of several reports received from the same source.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain
Clinical narrative: This is in follow-up to report (s) previously submitted on 6/14/2007. Information has been received from a pharmacist concerning an approximately 73 year old female with a history of shingles who on 21-MAR-2007 was vaccinated with a dose of ZOSTAVAX vaccine. Concomitant therapy was not reported. It was reported by the pharmacist that the patient was administered ZOSTAVAX (Merck) and was diagnosed with a case of shingles. The pharmacist administered the vaccination. Follow-up information was received by the consumer indicating that on "about" 22-APR-2007 she experienced pain and then developed shingles. She stated that she went to to an urgent care treatment center and they did not treat her as they said "She was one week too late for treatment". She stated that they put her on pain medication to help her with pain. In regards to recovering the patient stated that she was still having pain and some lesions. The patient stated that she had not seen her physician. No product quality complaint. No additional information was reported. Additional information is not expected.
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Ear pain, Herpes zoster
Clinical narrative: Information has been received from a medical technician concerning an 82 year old postmenopausal female with hypertension and no allergies who on 03-MAY-2007 was vaccinated with a dose of Zostavax (lot # 656606/0033U). There was no illness at the time of vaccination. On approximately 05-MAY-2007, the patient experienced ear pain. The patient went to the urgent care clinic and was prescribed acyclovir although a diagnosis of shingles was not reported by the patient. The patient was currently recovering. Medical attention was sought. No product quality complaint was involved. Additional information has been received from the medical technician who reported that on 05-MAY-2007, the patient developed an ear ache and two days later was seen at an urgent care clinic where she was placed on oral ZOVIRAX 800 mg QID x 10 days. The patient recovered on 10-MAY-2007. The patient had no adverse events following prior vaccination. Medical records from the patient's experience indicated that the patient was seen in urgent care on 05-MAY-2007. Her current medications were noted to be losartan potassium (MSD). She had taken two oxycodone the evening of 04-MAY-2007. Her chief complaint was an ear ache which started on 04-MAY-2007. She had extreme pain on the left  side in the ear, down the face and neck. The physician's impression was ear pain/early shingle. IN addition to ZOVIRAX she was prescribed oral PERCOCET 10/650 one Q4H prn. She was to follow up if there was a rash or if she was not better in two to three days. No further information is expected.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Blepharitis, Cataract operation, Herpes zoster, Herpes zoster ophthalmic, Skin lesion
Clinical narrative: Information has been received from a physician concerning an approximately 60 year old male who was vaccinated with a dose of Zostavax. Subsequently six months after vaccination, the patient experienced an outbreak of ophthalmic shingles. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 6/24/2007. Follow-up information from the physician and registered nurse indicated that on 03-APR-2007 the patient developed herpes zoster.  He saw his opthalmologist at the onset of the right eye irritation and rash on forehead with a diagnosis of herpes zoster.  On 06-APR-2007 the patient was seen by the opthamologist and he had right eye irritation and inflammation at the lid margin.  The assessment was herpes zoster opthalmic, dendritic lesion.  The plan was VALTREX 1 gm TID, LOTEMAX 1 drop right eye QID and tears.  On 16-APR-2007 the patient was seen for follow-up and his herpes zoster opthalmic in the right eye was improved.  The plan was to taper the LOTEMAX and proceed with planned cataract surgery.  On 20-APR-2007 the patient cataract surgery was performed.  On 21-APR-2007 on exam, the patient's recent herpes zoster in the left eye was improving.  Subsequently the patient recovered.  No further information is expected.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Vaccination failure
Clinical narrative: Information has been received from a physician concerning an approximately 60 year old male who was vaccinated with a dose of Zostavax. Subsequently six months after vaccination, the patient experienced an outbreak of ophthalmic shingles. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 6/24/2007. Follow-up information from the physician and registered nurse indicated that on 03-APR-2007 the patient developed herpes zoster.  He saw his opthalmologist at the onset of the right eye irritation and rash on forehead with a diagnosis of herpes zoster.  On 06-APR-2007 the patient was seen by the opthamologist and he had right eye irritation and inflammation at the lid margin.  The assessment was herpes zoster opthalmic, dendritic lesion.  The plan was VALTREX 1 gm TID, LOTEMAX 1 drop right eye QID and tears.  On 16-APR-2007 the patient was seen for follow-up and his herpes zoster opthalmic in the right eye was improved.  The plan was to taper the LOTEMAX and proceed with planned cataract surgery.  On 20-APR-2007 the patient cataract surgery was performed.  On 21-APR-2007 on exam, the patient's recent herpes zoster in the left eye was improving.  Subsequently the patient recovered.  No further information is expected.
Age: 1.25
Sex: F
Vaccine: DTAP, HEPA, HIBV, PNC, VARZOS
Symptoms: Condition aggravated, Inappropriate schedule of drug administration, Off label use, Otitis media, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old female with no known allergies or medical history who on 07-MAY-2007 was inadvertently vaccinated with a dose of Zostavax (lot# 656608/0032U) instead of a dose of MMRV. Concomitant vaccination on the same day included a dose of DTaP (unspecified) (+) tetanus toxoid, a dose of Vaqta (inactive) (manufacturer unknown), a dose of PedvaxHIB, and a dose of Prevnar. The reporter stated that this was not a product confusion, it was an office staff error. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 6/14/2007. Additional information was received. The patient is a female weighing 35 pounds 1 oz and height of ?? inches tall at the time of the report. The patient had a recent episode of otitis media and "had just finished unspecified antibiotic therapy a few days prior to vaccination. On 07-May-2007 the patient was vaccinated intramuscularly in the right thigh with a dose of OMPC, MSD, a dose of PEDIARIX, lot # AC14B040AA and a dose of PREVNAR, lot # D08684B and intramusculary in the left thigh with a dose of hepatitis A vaccine inactivated (lot # 65433B/0604F). The patient experience no adverse event. No further information is available.
Sex: U
Vaccine: VARZOS
Symptoms: Condition aggravated, Post herpetic neuralgia
Clinical narrative: Information has been received from a physician concerning a male patient with post herpetic neuralgia, no allergies and a history of shingles who was vaccinated with 0.65 ml dose of Zostavax. The patient's post herpetic neuralgia pain got worse after vaccination. At the time of report the patient did not recover. Unspecified medical attention was sought. A product quality complaint was not involved.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, PNC, VARZOS
Symptoms: Inappropriate schedule of drug administration, No adverse effect, Off label use, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old female with no known allergies or pertinent medical history who on 09-MAY-2007 was inadvertantly vaccinated SC with a dose of Zostavax (lot # 656606/0033U) instead of MMRV. Concomitant vaccination included a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown), poliovirus vaccine (manufacturer unknown) and Prevnar. Unspecified medical attention was sought. The patient had no symptoms or adverse effects. There were no lab tests performed. There was no product quality complaint involved. No further information was provided. Additional information has been requested. This is one of several reports from the same source. This is in follow-up to report (s) previously submitted on 6/14/2007. Additional information has been received from the registered nurse who stated tht the error occurred because the bottles of the vaccines were kept in the same place and they looked similar. It was reported that now they are store vaccines seperately to prevent the product confusion. The vaccination of patient and her sibling. No further information is available. This one of several reports from the same source.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster ophthalmic
Clinical narrative: Information  has been received from a physician concerning a patient who was vaccinated with a dose of Zostavax. it was reported that a day after vaccine was administered, the patient developed zoster of the eye. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a certified medical assistant concerning a 4 year old male patient who on 09-MAY-2007 was vaccinated SC with a dose of Zostavax (Merck) (Lot #656412/1476F) instead of varicella virus vaccine (Merck). It was reported that there was no product confusion just a medical error. It was also noted that the patient received a previous dose of varicella virus vaccine (Merck) on 18-FEB-2004. No problems were reported. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 6/14/2007. Additional information has been received from the certified medical assistant who stated that patient did not experience any adverse reaction. He was checked for couple of days. The patient did not have bumps or swelling. No further information is expected.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Rash erythematous, Rash papular, Rash pustular
Clinical narrative: Information has been received from a 69 year old male patient with a "kidney issue", ragweed allergy and urinary tract disorder who on 03-MAY-2007 was vaccinated with 0.5 ml dose of Zostavax. Concomitant therapy included ezetimibe (+) Simvastatin. On 09-MAY-2007 the patient developed rash on left collar bone are which was very painful. As per patient, the rash was red and bumpy with "maybe" two spots of pustule activities. Unspecified medical attention was sought. At the time of report, the patient was not recovered. No diagnostic laboratory tests were undertaken. A product quality complaint was not involved. Additional information has been requested.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a 70 year old male patient who "recently" in approximately May 2007 was vaccinated SC with 0.65 ml dose of Zostavax. It was reported that in approximately May 2007, the patient developed a rash "in his groin area". The physician is not sure if the rash is from the vaccine or not. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a male patient who was vaccinated SC with a dose of Zostavax. It was reported that the patient "broke out in a rash" after vaccination. Patient was treated with valacyclovir hydrochloride (VALTREX) by another physician. The reporting physician did not think that rash was shingles. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal pain
Clinical narrative: Information has been received from a physician concerning a 75 year old female who on approximately 04-APR-2007 was vaccinated SC with a dose of Zostavax. On approximately 03-MAY-2007 the patient developed musculoskeletal pain in the left arm. Unspecified medical attention was sought. Subsequently on 08-MAY-2007, the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Fatigue, Nausea
Clinical narrative: Information has been received from a physician concerning a 69 year old female patient who was vaccinated with a dose of Zostavax. It was reported that the patient experienced joint pain, nausea and fatigue after vaccination. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested. This is one of several reports received from the same source.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Information has been received from a 61 year old female consumer with wheat, rye and barley allergies, crohn's disease, coeliac disease and "PSC" who on 01-MAY-2007 was vaccinated with a 0.65 ml dose of Zostavax. Concomitant therapy included ursodiol (URSO) and mesalamine (ASACOL). On 02-MAY-2007 the patient developed swelling, itchiness, redness and soreness on her arm around the injection site. There was no laboratory tests performed. Unspecified medical attention was sought. Subsequently, the patient recovered on 08-MAY-2007. No product quality complaint was involved. No further information is expected.
Age: 6.0
Sex: M
Vaccine: VARCEL, VARZOS
Symptoms: Inappropriate schedule of drug administration, Off label use, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old male with no medical history or allergies who on 10-MAY-2007 was vaccinated SC on right thigh with the first 0.5 ml dose of Zostavax (Lot# 656859/0357U) instead of a dose of Varivax. There was no illness at the time of vaccination. It was reported as human error and not a product confusion. The nurse reported that child did not experience any difficulties. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.  Additional information has been recived from the registered nurse who stated that child had no adverse reaction. It was reported that there was nothing seen on the site of vacccination. No diagnostic laboratory teta were undertaken.  No further information is expectcted.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site mass
Clinical narrative: Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of Zostavax. Subsequently the patient experienced raised bump the size of a quarter after vaccination. Patient were advised to take non-steroidal anti-inflammatory drugs (NSAIDs) and apply ice to the site. The symptoms have occurred about a day or so after administration of the vaccine and dissipated a day later. No product quality complaint. This is one of several reports received from the same source. Additional information has been requested.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a pharmacist concerning an 82 year old male patient who on 07-MAR-2007 was vaccinated SC with a dose of ZOSTAVAX vaccine (Merck). On approximately 07-MAY-2007, two months after vaccination, the patient developed an outbreak of herpes zoster on his back. The patient was examined by his physician and was prescribed a course of VALTREX. At the time of report, the patient was not recovered. A product quality complaint was not involved. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 6/14/2007.  Additional information has been received from the pharmacist who stated that the outbreak of shingles was a normal occurrence to a live vaccine. No further information is expected.
Age: 78.0
Sex: M
Vaccine: VARZOS
Symptoms: Dysphagia, Pharyngitis
Clinical narrative: Information has been received from a 78 year old male on 03-MAY-2007 was vaccinated with a dose of Zostavax. On approximately 03-MAY-2007, the patient experienced throat infection and difficulty swallowing. No further information is available.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster ophthalmic
Clinical narrative: Information has been received from a physician concerning a female over 60 years of age with a history of shingles who on approximately 16-APR-2007 was vaccinated with 0.65 ml dose of Zostavax. On approximately 30-APR-2007 two weeks after vaccination, the patient experienced shingles in her eyes. At the time of report the patient was not recovered. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Information has been received from a pharmacist concerning a female patient who on 11-MAY-2007 was vaccinated with a dose of Zostavax. On 14-MAY-2007, the patient developed an injection site rash. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a female with a history of shingles two years back who on approximately 12-APR-2007 was vaccinated SC with a dose of Zostavax. On approximately 26-APR-2007 two weeks after vaccination, the patient experienced shingles. It was reported that "patient insisted on receiving vaccine even though she had a case of shingles 2 years ago". Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 78.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Seborrhoeic dermatitis
Clinical narrative: Information has been received from a physician concerning a male patient (age unknown) who in March 2007, was vaccinated with a dose of Zostavax. In March 2007, the patient experienced raised rash on scalp and one unspecified eyebrow. The patient did not recover. Unspecified medical attention was sought. No product quality complaint. Additional information has been requested. This is in follow-up to reports previously submitted on 6/14/2007. Information has been received from a physician and a dermatologist concerning a 78 year old male (Weight 217#. Height 68*) with hypertension, hyerlipiedema, osteoarthritis and penicillin allergy and a history of nasal disorder (unspecified 2000) who on 12-MAR-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (Lot# 656413/147F). Concomitant therapy included PREVACID, vitamins (unspecified). ECOTRIN, LASIX and felodipine. In March 2007.the patient experienced seborrheic dermatitis scalp, brows and ears. The dermatologist reported that the patient has never really had this before, therefore, this could have been an immunologic reaction to the antigenic stimulation. The patient was treated with PRAMOSONE lotion for his brows and ears and T-Gel which the patient already used some alternating with LOPROX shampoo and OLUX FOAM to scalp. The patient had an area of erythema just at the superior edge where the dermatologist worked on his nose in 2000. The patient also had a couple of comedonal cysts there that were incised and expressed. The patient was treated with METROGEL for the comedonal cysts. The patient will be re-evaluated in a month to see if the patient will need biotin or not. The patient's seborrhalc dermatitis scalp, brows and ears persisted. At the time of reporting, treatment was ongoing. There was no product quality complaint. Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site bruising, Injection site haematoma, Oedema peripheral
Clinical narrative: Information has been received from a physician concerning a 60 year old female office employee who "about 3 weeks ago" on approximately 23-APR-2007 was vaccinated with a 0.65 ml dose of ZOSTAVAX vaccine (Merck). Subsequently, "soon after receiving the shot" the patient experienced a hematoma on her arm, swollen arm, and a bruise around the injection site. Unspecified medical attention was sought. At the time of the report the patient was recovering. There was no product quality complaint involved. No further information was provided. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 6/14/2007. Information has been received from a physician and a 66 year old (also reported as 60 year old) female employee (adm) who on 30-MAR-2007 (also areported as "about 3 weeks agao") was vaccinated with a 0.65 ml (also reported as 0.7 ml) dose of ZOSTAVAX vaccine (Merck). Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL, VARZOS
Symptoms: Inappropriate schedule of drug administration, No adverse effect, Off label use, Wrong drug administered
Clinical narrative: Information has been received from a health professional concerning a 5 year old male who was vaccinated with a dose of Zostavax. No adverse reactions were reported. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been received from the health professional who stated that the patient was supposed to receive a dose of Varivax instead of a dose of Zostavax. The error occurred because both vaccines were stored in the same location and a wrong vaccine was grabbed. The child was reported to be "fine". It was reported that now both vaccines are being kept in different containers and are clearly labeled. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Information has been received from a 61 year old female patient with no medical history or allergies who on 10-MAY-2007 was vaccinated SC with a dose of Zostavax. There was no concomitant medication. It was reported that 24 hours after vaccination, on 11-MAY-2007 the patient experienced local heat and developed redness, both above and below the injection site. No other symptoms were reported. No diagnostic laboratory procedures were undertaken. At the time of reporting, the patient was recovering. A product quality complaint was not involved. Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Polymerase chain reaction, Rash vesicular
Clinical narrative: Information has been received from a physician concerning an approximately 68 year old female patient who on 19-APR-2007 was vaccinated SC with 0.65 ml dose of Zostavax (Lot #656606/0033U). There was no concomitant medication. On 06-MAY-2007 the patient experienced varicella like rash on back, trunk and arms. A diagnostic laboratory "PCR test" was undertaken on unspecified date. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of drug administration, Injection site rash, Off label use, Pain, Pain in extremity
Clinical narrative: Information has been received from a pharmacist concerning a 53 year old male with diabetes who on 07-MAY-2007 was vaccinated SC with 0.65 ml dose of Zostavax (Lot # 656395/0290U). On 08-MAY-2007 the patient developed local injection site rash and a shingles type rash on feet that reached up to his ankles. It was reported that the rash on his feet was itchy and painful. No diagnostic laboratory tests were undertaken. Unspecified medical attention was sought. At the time of report the patient was recovering. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report (s) previously on 6/14/2007. The patient recovered "about a week" after onset. A product quality complaint was not involved. No further information is available.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash pruritic, Rash vesicular
Clinical narrative: Information has been received from a pharmacist concerning a 53 year old male with diabetes who on 07-MAY-2007 was vaccinated SC with 0.65 ml dose of Zostavax (Lot # 656395/0290U). On 08-MAY-2007 the patient developed local injection site rash and a shingles type rash on feet that reached up to his ankles. It was reported that the rash on his feet was itchy and painful. No diagnostic laboratory tests were undertaken. Unspecified medical attention was sought. At the time of report the patient was recovering. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report (s) previously on 6/14/2007. The patient recovered "about a week" after onset. A product quality complaint was not involved. No further information is available.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Medication error
Clinical narrative: Information has been received from a medical assistant concerning a 67 year old female patient with hypertension, diabetes, increased triglycerides and no allergies who on  11-MAY-2007 was vaccinated SC with a dose of Zostavax (Oka/Merck) (Lot # 656395/0290U). There was no concomitant medication. On 12-MAY-2007 the patient experienced swelling, redness and itching at injection site. It was reported that the vaccine was stored in refrigerator for 30 minutes before vaccination. The patient was treated with ibuprofen. On 14-MAY-2007 the patient recovered. No diagnostic laboratory procedures were undertaken. A product quality complaint was not involved. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Eye pruritus, Oedema peripheral, Pain in extremity, Pharyngolaryngeal pain
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a dose of Zostavax (Oka/Merck). On an unspecified date, the patient developed joint pain, leg pain, swelling in the legs, pruritus in the eyes, and sore throat. The events did not appear until three to four days after receipt of the vaccine. As of 09-MAY-2007, the patient had not recovered. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Information has been received from a physician concerning a patient who on 11-MAY-2007 was vaccinated with a dose of Zostavax (Oka/Merck). On 11-MAY-2007 the patient developed redness at the injection site. No other symptoms were noted. Unspecified medical attention was sought. a
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated IM with 0.65 ml dose of Zostavax (Merck). It was reported that the patient developed shingles. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 6/14/2007. Additional information has been received from the medical assistant who stated that they had "no patients who have had a reaction". Additional information has been requested.
Age: 10.0
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: Medication error, No adverse reaction, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old patient who was vaccinated SC with 0.5 ml dose of Zostavax (Lot # 657675/0618U) instead of Varivax. It was reported that the office was expecting an order of Varivax and an order of Zostavax and the Zostavax vaccine arrived first. According to the nurse, vaccine boxes looked similar and thus the Zostavax box was put into children's freezer instead of adult freezer. The nurse also reported that the names of both vaccines sound similar. The patient did not experience any known symptoms. Unspecified medical attention was sought. A product quality complaint was not involved. This is one of several reports received from the same source. Additional information has been requested.
Age: 8.0
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old patient who was vaccinated with a dose of Zostavax instead of Varivax. It was reported that it was due to nursing error. No symptoms were noted. A product quality complaint was not involved. Additional information has been requested from the registered nurse who stated that the event occurred because both vaccines were stored in the freezer and an employee grabbed the wrong box. It was noted that the employee was new and was just confused. It was reported that they now have put a tape on Zostavax that says it is for adults only. Additional information has been requested. This is one of several reports received from the same source.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Musculoskeletal stiffness
Clinical narrative: Information has been received from a physician concerning a 65 year old black male with no known drug allergies who on 10-MAY-2007 (previously reported as 15-MAY-2007) was vaccinated in the left arm with a dose of Zostavax (lot #656859/0357U). Concomitant therapy included LIPITOR, NEXIUM, ZYRTEC, aspirin and lisinopril. Subsequently the patient the patient developed a headache and arm stiffness in his vaccinated arm. Unspecified medical attention was sought. No laboratory tests were performed. There was no product quality complaint involved. Additional information indicated that on 16-NOV-2007 at 09:30 the patient complained of stiffness in his left arm which proceeds to get worse and that his head hurt. The physician advised the patient to take ibuprofen 400 mg prn and if not better in 24 hours to call the office. Additional information has been requested.
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Information has been received from a physician concerning an 82 year old female with metastatic breast cancer on chemotherapy, coronary disease, diabetes, chronic kidney disease and hypertension who on 30-APR-2007 was vaccinated with a dose of Zostavax. Concomitant therapy included OXYCONTIN, hydrochlorothiazide, glipizide, omeprazole, PERCOCET, lisinopril (manufacturer unknown), NORVASC, LYRICA, LIPITOR, citalopram, calcium (unspecified), HERCEPTIN and paclitaxel. On approximately 04-MAY-2007 the patient developed a rash which was cutaneous eruptions of zoster on her abdomen and perivaginal area. Unspecified medical attention was sought. The patient was treated with famcyclovir and the rash was getting better. There were no laboratory tests performed. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a female physician who on approximately 10-MAY-2007 was vaccinated with a 0.65 ml dose of Zostavax. Subsequently on approximately 10-MAY-2007, the physician developed a red, very large swollen arm at the injection site. Unspecified medical attention was sought. At the time of the report, the physician had not recovered. No product quality complaint was involved. Additional information has been requested.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, Nausea
Clinical narrative: Information has been received from a physician concerning a 71 year old male patient who was vaccinated with a dose of Zostavax. It was reported that the patient experienced nausea and fatigue after vaccination. Additional information has been requested. This is one of several reports received from same source. 09/24/2007 This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a physician concerning a 70 year old male with high blood pressure, increased lipids and decreased vitamin D and a history of melanoma, bundle branch block right, prostatic specific antigen increased, right eye retinal detachment, raised liver function test, gout, cataract and appendectomy who on 09-MAY-2007 was vaccinated SC with a dose of ZOSTAVAX (Oka/Merck) (Lot # 656859/0357U). On 09-MAY-2007 in evening the patient experienced nausea and fatigue after vaccination. Additional information has been received from health professional who stated that patient had a wave of nausea and fatigue the night of vaccination. This is one of several reports received from same source. No further information is expected.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Oedema peripheral, Pruritus
Clinical narrative: Information has been received from a pharmacist concerning a 62-year-old female who in September 2006, was vaccinated with 0.65 milliliters of Zostavax. Subsequently, the patient experienced a swollen arm, sore underarm and her right arm was itchy. Unspecified medical attention was sought. No laboratory/diagnostic tests were performed. It was reported that the patient recovered. No product quality complaint was involved. Additional information is not expected.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Injection site erythema, Injection site pruritus, Skin lesion, Viral DNA test positive
Clinical narrative: Information has been received from a health care worker concerning a 68 year old female with no allergies who on 16-FEB-2007 was vaccinated SC with Zostavax (Lot # 656608/0032U). Concomitant therapy included alendronate sodium, PREVACID, and AMBIEN. On 08-MAY-2007 the patient developed itchy, red, lesions near the injection site on her left arm. The rash was diagnosed as shingles. Unspecified medical attention was sought. A diagnostic laboratory test of skin scrapping for varicella zoster virus was undertaken which was positive. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from an office manager concerning a 70 year old female with no medical conditions who was vaccinated (SC) in the right arm with a first dose of ZOSTAVAX (Merck) (lot # 656861/0329U). There was no illness at the time of vaccination. Subsequently, "the patient developed redness and swelling around the injection almost immediately following vaccination". Unspecified medical attention was sought. No product quality complaint was involved. No further information is expected.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Secondary transmission
Clinical narrative: Information has been received from a 58 year old female registered nurse with a history of chickenpox at the age of 5 years and shingles in 2005 who on 04-MAY-2007 at 12:15 PM administered a first dose SC on the left arm a dose of Zostavax (Lot # 656395/0290U) to a 60 year old female patient. There was no illness at the time of vaccination. On 06-MAY-2007 at 9:00 AM, two days after administrating vaccine, the nurse patient had a break out of shingles. IT was reported that nurse used hand washing before and after administrating vaccine but did not wear gloves or mask. On 09-MAY-2007, the nurse was seen by a physician and was diagnosed with shingles (right trigeminal lesions). Treatment included one week of valcyclovir hydrochloride (VALTREX0. At the time of report, the nurse had not recovered. Additional information has been requested.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Hypoaesthesia, Musculoskeletal stiffness, Oedema peripheral, Pain in extremity
Clinical narrative: Information has been received from a pharmacist and a 62 year old physician reporting on himself who on 17-MAY-2007 was vaccinated with Zostavax. On the morning of 19-MAY-2007 the patient developed severe, painful, peripheral edema of the left hand. There was swelling, numbness and stiffness of the hand. The hand looked like there was potential for infection so the physician started himself on intravenous (IV) ROCEPHIN on 22-MAY-2007 with no improvement. The physician has been treating the hand with elevation and warm soaks, as per the advice of an infectious disease doctor. Treatment has also consisted of ASPERCREME with little relief and ADVIL, however, the hand is still the same. As of 24-MAY-2007, the physician described the event as a severe reaction. As of 25-MAY-2007, approximately eight days after the swelling in the hand began, it still persisted and was still painful. As of 08-JUN-2007, the swelling had resolved. The physician mentioned that the swelling could have been from a spider bite. Unspecified medical attention was sought. No product quality complaint was involved. Additional information is not expected.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased, Injection site pain, Myalgia
Clinical narrative: Information has been received from a registered nurse concerning a 75 year old female with a cardiac history who sometime in the first week of March 2007, was vaccinated with a subcutaneous dose of Zostavax. Concomitant therapy included cardiac medication (unspecified). "Shortly after she got the Zostavax vaccine", in approximately 3007, the patient experienced soreness at the site of the injection, pain in the muscle and it hurt when she moved her arm. At the time of this report, the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.  Follow up: Information has been received from a 75 year old female registered nurse, reporting on herself, with allergies to pollen and perfume and a cardiac history who on 01-March-2007, was vaccinated with a .5cc subcutaneous dose of ZOSTAVAX (Merck) (Lot # "9035U") in the left deltoid. Concomitant therapy included cardiac medication (unspecified). About 3 days after vaccination with the ZOSTAVAX (Merck) on approximately 04-MAR-2007, the patient developed severe sharp pain which shot up the left upper arm from the elbow to the shoulder without pain in the joints. This lasted 3.75 months, mainly when lifting the arm. The patient recovered during the 4th week of June 2007. Unspecified medical attention was sought. No product quality complaint was involved.  Additional information is not expected.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood test normal, Headache, Headache, Incorrect route of drug administration, Laboratory test
Clinical narrative: This is in follow-up to report (s) previously submitted on 06/14/2007. Information has been received from a mid 70's year old female consumer with hypertension and hypercholesterolaemia and food allergies who on 14-MAY-2007 (also reported as 15-MAY-2007) was vaccinated IM with a dose of Zostavax. It was reported that on 14-MAY-2007 (also reported as 15-MAY-2007), 1 to 2 hours after vaccination, the patient experienced headache lasting from 4:30 PM 14-MAY-2007 until 19-MAY-2007. The consumer said she had called the physician on 15-MAY-2007 and saw him on 18-MAY-2008. Patient underwent a MRI on 18-MAY-2007 because of continuing headache pain. Blood test were undertaken. The results of both tests were normal. The consumer does not have past history of headache. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been received from the physician who reported that the patient developed a headache within 1-2 hours after vaccination. The headache persisted for 1 week. The patient was treated with a "mild liquid acetaminophen (TYLENOL) type" pain reliever. Additional information has been requested. Additional information has been received from the physician who stated that patient developed fronal headache within 2 hours on inoculation. Headach lasted for 6 days with no sequelae. Ophthalmological exam was undertaken by patient and the result was negative. The patient recovered in 1 week. No further information is expected.